Found 6 matching trials
Study of Varying Injection Schedules of TDENV-PIV Vaccine With AS03B Adjuvant and Placebo in Healthy US Adults
PHASE1This study is being conducted to evaluate the safety and immunogenicity and...
Location
University of Maryland, Center for Vaccine Development,
A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults
PHASE1The study is designed to afford a safety and immunogenicity assessment of t...
Location
WRAIR, Clinical Trials Center
Comparison of Tetravalent Dengue Virus Purified Inactivated Vaccine and Tetravalent Dengue Virus Live Attenuated Vaccine
PHASE1This study is a Phase 1, randomized, open-label study of the prime-boost va...
Location
WRAIR, Clinical Trials Center
A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults (in Puerto Rico)
PHASE1This is a first time in humans (FTiH) study designed to assess the experime...
Location
Clinical Research Center, 1st Floor University Hospital
TDENV PIV and LAV Dengue Prime-boost Strategy Using AS03B Adjuvant
PHASE1The potential synergistic effect of administering 2 dengue vaccine candidat...
Location
Upstate Medical University, SUNY
TDENV PIV and LAV Dengue Prime-boost Strategy
PHASE1The potential synergistic effect of administering 2 dengue vaccine candidat...
Location
Clinical Trials Center, Walter Reed Army Institute of Research (CTC, WRAIR)